Novel indel mutation in the N gene of SARS-CoV-2 clinical samples that were diagnosed positive in a commercial RT-PCR assay
- 19 March 2021
- journal article
- research article
- Published by Elsevier BV in Virus Research
- Vol. 297, 198398
- https://doi.org/10.1016/j.virusres.2021.198398
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- COVID-19 Molecular Testing in Korea: Practical Essentials and Answers From Experts Based on Experiences of Emergency Use Authorization AssaysAnnals of Laboratory Medicine, 2020
- Genomic and proteomic mutation landscapes of SARS‐CoV‐2Journal of Medical Virology, 2020
- Mutations on COVID-19 diagnostic targetsGenomics, 2020
- Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2mBio, 2020
- The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine DevelopmentJournal of Virology, 2020
- Assay Techniques and Test Development for COVID-19 DiagnosisACS Central Science, 2020
- The establishment of reference sequence for SARS‐CoV‐2 and variation analysisJournal of Medical Virology, 2020
- COVID‐2019: The role of the nsp2 and nsp3 in its pathogenesisJournal of Medical Virology, 2020
- MEGA X: Molecular Evolutionary Genetics Analysis across Computing PlatformsMolecular Biology and Evolution, 2018